QQQ   422.83 (-0.14%)
AAPL   166.82 (-0.13%)
MSFT   404.90 (+0.16%)
META   506.50 (+0.94%)
GOOGL   155.40 (-0.39%)
AMZN   178.78 (-0.25%)
TSLA   149.20 (-0.49%)
NVDA   846.50 (-0.02%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
F   12.05 (-0.08%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
DIS   111.77 (-0.59%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
XOM   118.75 (+0.19%)
QQQ   422.83 (-0.14%)
AAPL   166.82 (-0.13%)
MSFT   404.90 (+0.16%)
META   506.50 (+0.94%)
GOOGL   155.40 (-0.39%)
AMZN   178.78 (-0.25%)
TSLA   149.20 (-0.49%)
NVDA   846.50 (-0.02%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
F   12.05 (-0.08%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
DIS   111.77 (-0.59%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
XOM   118.75 (+0.19%)
QQQ   422.83 (-0.14%)
AAPL   166.82 (-0.13%)
MSFT   404.90 (+0.16%)
META   506.50 (+0.94%)
GOOGL   155.40 (-0.39%)
AMZN   178.78 (-0.25%)
TSLA   149.20 (-0.49%)
NVDA   846.50 (-0.02%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
F   12.05 (-0.08%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
DIS   111.77 (-0.59%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
XOM   118.75 (+0.19%)
QQQ   422.83 (-0.14%)
AAPL   166.82 (-0.13%)
MSFT   404.90 (+0.16%)
META   506.50 (+0.94%)
GOOGL   155.40 (-0.39%)
AMZN   178.78 (-0.25%)
TSLA   149.20 (-0.49%)
NVDA   846.50 (-0.02%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
F   12.05 (-0.08%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
DIS   111.77 (-0.59%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
XOM   118.75 (+0.19%)
Free Trial
LON:NCYT

Novacyt (NCYT) Share Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)
Free NCYT Stock Alerts
GBX 67.50
+3.10 (+4.81%)
(As of 02:03 PM ET)
Compare
Today's Range
62.20
▼
70
50-Day Range
43
▼
64.40
52-Week Range
35.80
▼
86
Volume
339,669 shs
Average Volume
92,817 shs
Market Capitalization
£47.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsHeadlinesInsider Trades
NCYT stock logo

About Novacyt Stock (LON:NCYT)

Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. The company was incorporated in 2006 and is based in Vélizy-Villacoublay, France.

NCYT Stock Price History

NCYT Stock News Headlines

April 19, 2024 | actusnews.com
DHSC Claim update - Pre-Trial Review
April 13, 2024 | lse.co.uk
AstraZeneca increases 2024 dividend by 7%
April 19, 2024 | Altimetry (Ad)
I’m officially sounding the alarm.
AI has been the hottest financial story of 2023. And rightly so – AI stocks have beat the broader market by over 62%. But right now, my system is warning me that many AI stocks are riding higher on hype alone.
April 11, 2024 | actusnews.com
Directorate Changes and FY 23 results update
February 6, 2024 | actusnews.com
Update on Taiwanese divestment
January 30, 2024 | morningstar.com
Novacyt SA NYZ
January 25, 2024 | actusnews.com
Trading update
September 30, 2023 | actusnews.com
Reminder to shareholders re. AGM voting
April 19, 2024 | Altimetry (Ad)
I’m officially sounding the alarm.
AI has been the hottest financial story of 2023. And rightly so – AI stocks have beat the broader market by over 62%. But right now, my system is warning me that many AI stocks are riding higher on hype alone.
September 11, 2023 | actusnews.com
Cancellation of trading of Yourgene Shares
August 29, 2023 | actusnews.com
Notice of rescheduled AGM
July 3, 2023 | proactiveinvestors.com
Yourgene jumps 143% on Novacyt £16.7m knock-out bid
June 24, 2023 | lse.co.uk
Chipotle Mexica Share Chat
June 14, 2023 | lse.co.uk
Nordtelekom Nyr Share Chat
June 12, 2023 | lse.co.uk
Calipso Oradea Share Chat
May 26, 2023 | actusnews.com
Publication of Annual Report and AGM voting
January 30, 2023 | finance.yahoo.com
Novacyt S.A. ("Novacyt", the "Company" or the "Group"): DHSC Claim Update – Trial Date Listed
January 26, 2023 | finance.yahoo.com
Novacyt S.A. ("Novacyt", the "Company" or the "Group") Full Year 2022 Trading Update
December 7, 2022 | finance.yahoo.com
Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Non-Executive Director Change
December 6, 2022 | finance.yahoo.com
Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Approval of genesig® COVID-19 3G PCR Test in the UK Under CTDA Legislation
November 10, 2022 | finance.yahoo.com
Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Directorate Change
October 26, 2022 | proactiveinvestors.com
Novacyt gains UK approval for its multiplex PCR test for detection of winter viruses
October 26, 2022 | proactiveinvestors.com
Novacyt approved for COVID and winter viruses PCR test
October 10, 2022 | thetimes.co.uk
Your three-minute digest - The Times
October 10, 2022 | marketscreener.com
Novacyt Faces $150 Million Legal Claim For Inconsistent COVID-19 Testing Results In UK - Marketscreener.com
October 9, 2022 | thetimes.co.uk
Novacyt subject to legal claim after 'troubling' Covid test results - The Times
October 6, 2022 | businesswire.com
Outlook on the High-Resolution Melting Analysis Global Market to 2027 - Featuring Agilent Technologies, Azura Genomics, Illumina and Novacyt Among Others - ResearchAndMarkets.com - Business Wire
See More Headlines
Receive NCYT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novacyt and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
LON:NCYT
CUSIP
N/A
CIK
N/A
Web
www.novacyt.com
Phone
33 1 39 46 51 04
Fax
N/A
Employees
120
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
GBX (0.36)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-25,300,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-21.08%
Return on Assets
-5.88%

Debt

Debt-to-Equity Ratio
0.36
Current Ratio
5.09
Quick Ratio
4.46

Sales & Book Value

Annual Sales
£7.87 million
Price / Sales
5.92
Cash Flow
GBX 113.71 per share
Price / Cash Flow
0.58
Book Value
GBX 152 per share
Price / Book
0.43

Miscellaneous

Outstanding Shares
70,630,000
Free Float
N/A
Market Cap
£46.62 million
Optionable
Not Optionable
Beta
-1.73
The 10 Best AI Stocks to Own in 2024 Cover
The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. James Martin McCarthy (Age 58)
    Acting CEO & Director
    Comp: $354.52k
  • Mr. Steve Gibson
    CFO & Director
  • Bryan Close
    Chief Operations Officer
  • Ms. Mandy Cowling
    Corporate & Investor Relations Manager
  • Mr. David Franks
    Chief Human Resources Officer
  • Paul Oladimeji
    Group Head of R&D
  • Mr. Lyn Dafydd Rees (Age 51)
    Executive Director

Key Competitors

View All Competitors

NCYT Stock Analysis - Frequently Asked Questions

How have NCYT shares performed in 2024?

Novacyt's stock was trading at GBX 61.50 at the beginning of the year. Since then, NCYT stock has increased by 9.8% and is now trading at GBX 67.50.
View the best growth stocks for 2024 here.

What other stocks do shareholders of Novacyt own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Novacyt investors own include Biocept (BIOC), Ecolab (ECL), genedrive (GDR), Geron (GERN), Immunic (IMUX), Tiziana Life Sciences (TILS), Verastem (VSTM), VYNE Therapeutics (VYNE), Antero Midstream (AM) and Aileron Therapeutics (ALRN).

How do I buy shares of Novacyt?

Shares of NCYT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:NCYT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research